Literature DB >> 8358979

Increased soluble IL-2 receptor in serum of patients with systemic lupus erythematosus.

S Sawada1, H Hashimoto, S Iijma, Y Tokano, Y Matsukawa, M Takei, H Ishikawa, H Kang, K Tomura, K Mitamura.   

Abstract

We estimated the concentration of soluble IL-2R (sIL-2R) in the serum of patients with systemic lupus erythematosus (SLE) and examined the relationship between the serum levels of sIL-2R and clinical features or laboratory data. We found that elevated levels of sIL-2R were present in the serum of SLE patients with discoid rash, and sIL-2R concentrations were correlated with the soluble CD4 and soluble CD8 concentrations but not with classical serological marker, anti-DNA antibody or complement titer.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8358979     DOI： 10.1007/bf02231527

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  22 in total

Review 1.  Disordered immunologic regulation and autoimmunity.

Authors:  N Talal
Journal:  Transplant Rev       Date:  1976

Review 2.  Autoimmunity--a perspective.

Authors:  H R Smith; A D Steinberg
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

3.  Spontaneous and pokeweed mitogen-induced plaque-forming cells in systemic lupus erythematosus.

Authors:  G C Tsokos; J E Balow
Journal:  Clin Immunol Immunopathol       Date:  1981-11

4.  Soluble IL-2 receptor in AIDS. Correlation of its serum level with the classification of HIV-induced diseases and its characterization.

Authors:  M Honda; K Kitamura; K Matsuda; Y Yokota; N Yamamoto; R Mitsuyasu; J C Chermann; T Tokunaga
Journal:  J Immunol       Date:  1989-06-15       Impact factor: 5.422

5.  Cell-mediated immunity in rheumatic diseases. II. Mitogen responses in RA, SLE, and other illnesses: correlation with T- and B-lymphocyte populations.

Authors:  M D Lockshin; A C Eisenhauer; R Kohn; M Weksler; S Block; S B Mushlin
Journal:  Arthritis Rheum       Date:  1975 May-Jun

6.  Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE).

Authors:  M Linker-Israeli; A C Bakke; R C Kitridou; S Gendler; S Gillis; D A Horwitz
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

7.  Immune activation in measles.

Authors:  D E Griffin; B J Ward; E Jauregui; R T Johnson; A Vaisberg
Journal:  N Engl J Med       Date:  1989-06-22       Impact factor: 91.245

8.  Increased levels of soluble CD8 molecule in the serum of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related disorders.

Authors:  C Agostini; G Semenzato; F Vinante; A Sinicco; L Trentin; R Zambello; B Zuppini; R Zanotti; F Siviero; D Veneri
Journal:  Clin Immunol Immunopathol       Date:  1989-01

9.  Failure of regulation of Tac antigen/TCGF receptor on adult T-cell leukemia cells by anti-Tac monoclonal antibody.

Authors:  M Tsudo; T Uchiyama; H Uchino; J Yodoi
Journal:  Blood       Date:  1983-05       Impact factor: 22.113

10.  Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

Authors:  L A Rubin; C C Kurman; M E Fritz; W E Biddison; B Boutin; R Yarchoan; D L Nelson
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422
View more
  3 in total

Review 1.  The contribution of interleukin-2 to effective wound healing.

Authors:  Karen M Doersch; Daniel J DelloStritto; M Karen Newell-Rogers
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-25

Review 2.  Beyond regulatory T cells: the potential role for IL-2 to deplete T-follicular helper cells and treat autoimmune diseases.

Authors:  André Ballesteros-Tato
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

3.  Significance of stem cell factor and soluble KIT in patients with systemic lupus erythematosus.

Authors:  T Kitoh; H Ishikawa; S Sawada; K Koshino; Y Tokano; H Hashimoto; S Nakagawa
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.